BackgroundThe treatment of metastatic hormone-sensitive prostate cancer (mHSPC) has shifted from androgen deprivation therapy (ADT) alone to doublet or triplet regimens building on ADT. However, the c

NIAID Data Ecosystem10

One-way sensitivity analyses comparing EV71 vaccination with no EV71 vaccination at various prices per dose (US Dollars in 2012).

经济学评价

成本敏感性分析

One-way sensitivity analyses comparing EV71 vaccination with no EV71 vaccination at various prices per dose (US Dollars in 2012).

NIAID Data Ecosystem50

QALYs gained and costs per 100,000 person-years.

经济学评价

成本效益分析

QALYs gained and costs per 100,000 person-years.

Figshare2018-04-11 更新20

<p>ICER (Incremental cost-effectiveness ratio) for scenario I.</p>

资源简介：

相关数据集